Your browser doesn't support javascript.
loading
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19.
Lee, Chan Mi; Choe, Pyoeng Gyun; Kang, Chang Kyung; Lee, Eunyoung; Song, Kyoung-Ho; Bang, Ji Hwan; Kim, Eu Suk; Kim, Hong Bin; Kim, Nam Joong; Kim, Hang-Rae; Kim, Youngju; Lee, Chang-Han; Shin, Hyun Mu; Park, Sang-Won; Park, Wan Beom; Oh, Myoung-Don.
Afiliação
  • Lee CM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choe PG; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kang CK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee E; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Song KH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Bang JH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim ES; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim HB; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Kim NJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim HR; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim Y; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee CH; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Shin HM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park SW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Park WB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Oh MD; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Front Immunol ; 14: 1106664, 2023.
Article em En | MEDLINE | ID: mdl-37033936

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapias Complementares / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapias Complementares / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article